FDA approves ataxia-telangiectasia drug; Alkermes reports ADHD data

Plus news about Biokin, Bristol Myers Squibb, Grünenthal and Johnson & Johnson. FDA approves ataxia-telangiectasia treatment: The agency approved the rare genetic disease treatment Aqneursa from the privately held biotech IntraBio ...